XEOMIN® (incobotulinumtoxinA) is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.

How Does XEOMIN® Work?
Frown lines form when facial expressions are made as the muscle under the skin contracts. Over time, as your skin ages, these repeated expressions cause lasting frown lines. Neurotoxins, such as XEOMIN® , are prescription medications that block the release of chemicals that cause these muscle contractions. So frown lines are softened.

How it Works
Before & After Results
See the difference in frown lines before and after treatment with XEOMIN® (incobotulinumtoxinA).
How it Works
Before & After Results
See the difference in frown lines before and after treatment with XEOMIN® (incobotulinumtoxinA).

XEOMIN® Before and After Photos at Maximum Frown

Raquel

RAQUEL, AGE 44
SEVERE GLABELLAR LINES

AFTER PHOTO TAKEN
30 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.

Michelle

MICHELLE, AGE 49
SEVERE GLABELLAR LINES

AFTER PHOTO TAKEN
30 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.

Tracy

TRACY, AGE 44
MODERATE GLABELLAR LINES

AFTER PHOTO TAKEN
30 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.

Cheri

CHERI, AGE 53
MODERATE GLABELLAR LINES

AFTER PHOTO TAKEN
14 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.

Claudia

CLAUDIA, AGE 39
SEVERE GLABELLAR LINES

AFTER PHOTO TAKEN
14 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.

Elisabeth

ELISABETH, AGE 46
SEVERE GLABELLAR LINES

AFTER PHOTO TAKEN
14 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.

Jill

JILL, AGE 45
SEVERE GLABELLAR LINES

AFTER PHOTO TAKEN
7 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.

Julie

JULIE, AGE 45
SEVERE GLABELLAR LINES

AFTER PHOTO TAKEN
7 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.

Barbara

BARBARA, AGE 38
MODERATE GLABELLAR LINES

AFTER PHOTO TAKEN
7 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.

Derek

DEREK, AGE 41
MODERATE GLABELLAR LINES

AFTER PHOTO TAKEN
7 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings) at Day 30.

 

XEOMIN® Before and After Photos at Rest

 

Julie

JULIE, AGE 45
SEVERE GLABELLAR LINES

AFTER PHOTO TAKEN
7 DAYS AFTER INJECTION

Individual results may vary. Unretouched photos. The highest proportion of patients achieved treatment success (at least 2 points improvement in both the investigator and patient ratings at maximum frown) at Day 30.